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Abstract
The present study investigated the influence of bacterial metabolites on monocarboxylate transporter 1 (MCT1) expression in pigs using
in vivo, ex vivo and in vitro approaches. Piglets (n 24) were fed high-protein (26 %) or low-protein (18 %) diets with or without fermentable
carbohydrates. Colonic digesta samples were analysed for a broad range of bacterial metabolites. The expression of MCT1, TNF-a,
interferon g (IFN-g) and IL-8 was determined in colonic tissue. The expression of MCT1 was lower and of TNF-a and IL-8 was higher
with high-protein diets (P,0·05). MCT1 expression was positively correlated with L-lactate, whereas negatively correlated with NH3
and putrescine (P,0·05). The expression of IL-8 and TNF-a was negatively correlated with L-lactate and positively correlated with NH3
and putrescine, whereas the expression of IFN-g was positively correlated with histamine and 4-ethylphenol (P,0·05). Subsequently,
porcine colonic tissue and Caco-2 cells were incubated with Na-butyrate, NH4Cl or TNF-a as selected bacterial metabolites or mediators
of inflammation. Colonic MCT1 expression was higher after incubation with Na-butyrate (P,0·05) and lower after incubation with NH4Cl
or TNF-a (P,0·05). Incubation of Caco-2 cells with increasing concentrations of these metabolites confirmed the up-regulation of MCT1
expression by Na-butyrate (linear, P,0·05) and down-regulation by TNF-a and NH4Cl (linear, P,0·05). The high-protein diet decreased
the expression of MCT1 in the colon of pigs, which appears to be linked to NH3- and TNF-a-mediated signalling.
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Dietary and endogenous proteins that enter the large intestine
of humans or monogastric animal species can be fermented
by indigenous bacteria to form metabolites such as NH3,
hydrogen sulphide, branched-chain fatty acids, phenols and
indols, which may promote intestinal disorders(1–4). For
example, protein level and quality in pig diets have been
shown to be related to diarrhoea and shedding of enterotoxi-
genic Escherichia coli after a challenge(5,6). A promising
approach to reduce the formation of harmful metabolites
from protein fermentation in the large intestine is the inclusion
of fermentable carbohydrates in the diet(4,7,8). This approach
can be used to direct bacterial fermentation activity towards
utilisation of carbohydrates instead of proteins, yielding
lower luminal concentrations of branched-chain fatty acids
and NH3 and higher levels of SCFA.
Among SCFA, butyrate is of specific interest, as it serves as a
source of energy for colonocytes and plays a crucial role in the
epithelial maintenance of gut barrier function(9). In addition
to non-ionic diffusion, carrier-mediated uptake of butyrate
from the large-intestinal lumen can also occur through
monocarboxylate transporter 1 (MCT1) expression. Increased
formation of butyrate from the fermentation of carbohydrates
has been shown to increase the expression of MCT1 in
pigs(10,11). MCT1 can also be induced by ketone bodies, pyru-
vate and lactate in addition to butyrate(12,13). Activation by
butyrate probably occurs through a butyrate response element
in the promoter region of the MCT1 gene(14). In contrast,
the expression of the MCT1 gene is down-regulated in
colonocytes during transition to malignancy(15). Moreover,
interferon g (IFN-g) and TNF-a signalling down-regulates
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MCT1 expression during inflammation, leading to butyrate
deficiency in intestinal epithelial cells(16).
Whether metabolites derived from intestinal protein fermen-
tation could influence the expression of MCT1 in pigs is yet
unknown. We have previously demonstrated that increased
formation of protein-derived metabolites in the large intes-
tine increases the expression of pro- and anti-inflammatory
cytokines, tight junction proteins and epithelial response to
histamine(17–19). Of these activities, the pro-inflammatory
response may suggest that MCT1 expression is potentially
down-regulated by high-protein diets. We hypothesised that
such down-regulation of MCT1 expression, if present, could
be dependent on the levels of both dietary protein and
fermentable carbohydrates, because these nutrients induce
microbial metabolites that, in turn, influence cytokine expre-
ssion. In addition to testing this core in vivo hypothesis,
we also used ex vivo (Ussing chamber) and in vitro (Caco-2
cells) approaches to further study the influence of NH3 and
TNF-a on the expression patterns of MCT1 and cytokines.
Materials and methods
All procedures involving pig handling and treatments were
approved by the State Office of Health and Social Affairs
‘Landesamt fu¨r Gesundheit und Soziales Berlin’ (LAGeSo
Reg. no. 0389/12).
Animals, diets and sampling
A total of twenty-four piglets (Euroc £ Pietrain) with a mean
body weight (BW) of 7·4 (SE 1·0) kg were weaned at 25 d of
age and randomly assigned to one of four dietary treatment
groups in a 2 £ 2 factorial arrangement, balancing for
sex and BW. Diets (Table 1) were formulated to meet or
exceed the nutrient requirements of the weaning pig(20). The
sources of dietary crude protein (CP) were soyabean meal,
fishmeal and potato protein. Fermentable carbohydrates
were supplied as sugarbeet pulp (SBP). Water and feed
were provided ad libitum. Feed intake and BW of pigs were
recorded weekly, and health status was checked daily.
Piglets were euthanised on experimental day 21 ^ 1 by an
intracardial injection of 10 mg/kg BW of tetracaine hydrochlo-
ride, mebezonium iodide and embutramide (T61w; Intervet)
after sedation with 20 mg/kg BW of ketamine hydrochloride
(Ursotaminw; Serumwerk Bernburg AG) and 2 mg/kg BW
of azaperone (Stresnilw; Janssen-Cilag). Following euthanasia,
digesta contents and tissue samples from the colon ascen-
dens were taken and immediately stored at 2808C until
further analysis.
Chemical analyses
Weende proximate nutrients (ash, CP and diethyl ether
extract) and starch were determined using standard
procedures(21). Total dietary fibre was analysed using a
commercial kit (Megazyme K-TDF; Megazyme), as described
previously(22). Trace mineral content in feedstuff was deter-
mined by atomic absorption spectrometry using an AAS
Vario 6 spectrometer (Analytik Jena) after hydrolysis of
samples in concentrated HCl.
D- and L-Lactate, NH3, SCFA, biogenic amines, phenols and
indols were determined in the digesta samples, as described
previously(17,22,23).
Ussing chamber experiments
Segments of the ascending colon from six piglets (age 54
(SE 2) d) fed a standard weaning diet (containing 18 % CP)
were collected immediately after euthanasia and settled in a
pre-warmed modified Ringer buffer solution, oxygenated
with 95 % O2–5 % CO2. The composition of the buffer was
111 mM-NaCl, 5 mM-KCl, 1·5 mM-CaCl2, 1·2 mM-MgCl2, 0·6 mM-
NaH2PO4, 2·4 mM-Na2HPO4, 25 mM-NaHCO3, 10 mM-glucose
Table 1. Ingredients and chemical composition of the experimental diets
Low CP High CP
Low SBP SBP Low SBP SBP
Ingredients (g/kg as fed)
Maize 450 341 300 300
Wheat 335 300 352 222
Soyabean meal (49 % CP) 110 120 140 140
Fishmeal 30 30 100 110
Potato protein 30 30 75 75
Sugarbeet pulp - 120 – 120
Monocalcium phosphate 9 9 5 5
Limestone 9 8 5 3
Mineral and vitamin
premix*
12 12 12 12
Salt 1 1 1 1
Soya oil 5 20 5 7
Lys HCl 3 3 – –
Trp 1 1 – –
TiO2 5 5 5 5
Metabolisable energy (MJ/kg) 13·4 13·2 13·5 13·3
Analysed composition (g/kg DM)
Ash 52 55 53 60
CP 183 179 256 255
Diethyl ether extract 33 38 29 33
Total dietary fibre 192 273 216 315
Insoluble dietary fibre 143 215 169 244
Soluble dietary fibre 48 58 47 71
Starch 450 376 350 308
Ca 8·7 8·6 8·7 8·5
P 5·8 5·5 6·5 6·5
Mg 1·8 2·1 1·7 2·0
Na 2·0 2·0 2·1 2·2
Analysed composition (mg/kg DM)
Zn 103 98 85 93
Mn 97 99 90 95
Cu 15 12 11 11
Fe 203 365 157 358
Calculated composition (g/kg DM)
Lys 12·5 13·0 17·4 18·1
Met 3·6 3·6 5·7 5·8
Thr 7·6 7·8 11·9 12·2
Trp 3·0 3·1 3·3 3·3
CP, crude protein; SBP, sugarbeet pulp.
* Mineral and vitamin premix (Spezialfutter Neuruppin GmbH) containing per kg
DM: 130 g Na (as NaCl); 55 g Mg (as magnesium oxide); 210 mg retinol; 3000mg
cholecalciferol; 8000 mg DL-a-tocopherol; 300 mg menadione; 250 mg thiamin;
250 mg riboflavin; 400 mg pyridoxine; 2000mg vitamin B12; 2500 nicotinic acid;
100 mg folic acid; 25 000 mg biotin; 1000 mg pantothenate; 80 000 mg choline
chloride; 5000 mg Fe (as iron (II) carbonate); 1000 mg Cu (as copper (II)
sulphate); 5000 mg Zn (as zinc oxide); 6000 mg Mn (as manganese (II) oxide);
45 mg I (as calcium iodate); 35 mg Se (as sodium selenite).

















and 2 mM-mannitol, and the pH was adjusted to 7·4. The
epithelium was stripped from the serosa and muscular
layers, and subsequently mounted on Ussing chambers
(exposed area 1·31 cm2). For each pig, six chambers were pre-
pared with two chambers per pig (including control) assigned
to each treatment, resulting in a total of six chambers with tis-
sues from three pigs per treatment. The apical and basolateral
surfaces of the tissues were rinsed with 15 ml of oxygenated
buffer solution and maintained at 378C in water-jacketed
reservoirs. Electrical measurements were obtained using a
microcomputer-controlled voltage/current clamp (K. Mussler
Scientific Instruments), as described previously(18). The
transepithelial potential difference in response to bipolar
50mA current pulses generated for 200 ms, and tissue con-
ductance (Gt) was calculated according to Ohm’s law. After
equilibration for approximately 15–30 min, tissues were
short-circuited by clamping the voltage at 0 mV. The test sub-
strates Na-butyrate and NH4Cl were added to the mucosal and
TNF-a to the serosal side of the tissue to give a final concen-
tration of 20 mmol/l, 20 mmol/l and 50 ng/ml, respectively,
with osmolality adjusted to 295 (SE 10) mOsmol/l. After 1 h
of incubation, the exposed portion of the tissue was harvested
and immediately stored in RNAlater RNA Stabilization Reagent
(Qiagen GmbH) at 2808C until use.
Caco-2 cell experiments
To study the influence of different concentrations of Na-
butyrate, NH4Cl and TNF-a on the expression of MCT1 and
cytokines, in vitro cell-culture experiments using Caco-2
cells were performed. Caco-2 cells were grown routinely in
a T-75 plastic flask at 378C in an atmosphere of 5 % CO2,
and maintained in Eagle’s minimum essential medium (LGC
Standards) supplemented with 20 % fetal bovine serum,
100 units penicillin/ml and 100mg streptomycin/ml (Bio-
chrom). Confluent Caco-2 cells were subcultured in a ratio
of 1:10 using 0·25 %/0·02 % trypsin–EDTA (Biochrom). For
the present experiment, cells were seeded on twenty-four-well
plates at a density of 105 cells/well and allowed to differentiate
for 21 d, with fresh medium replacement three times per
week. All cells used in the experiments were between passage
numbers 19 and 21. Caco-2 cells were treated with buffer of
the same composition as that used for electrophysiological
measurements indicated above (pH 7·2). Buffer media
contained increasing concentrations of Na-butyrate (10, 20
and 50 mmol/l), NH4Cl (5, 10 and 20 mmol/l) or TNF-a (25,
50 and 100 ng/ml). Osmolality was adjusted to 295 (SE 10)
mOsmol/l. After 1 h of incubation, cells were rinsed with the
buffer solution. The buffer was immediately replaced with
RNAlater RNA Stabilization Reagent, the cells were scraped
from the surface, and the solution was stored at 2808C for
the analyses of MCT1, IL-8 and TNF-a gene expression.
Gene expression analysis
Analysis of gene expression was performed as described pre-
viously with slight modifications(17,24). Briefly, total RNA from
colonic tissue and Caco-2 cells was extracted using the
NucleoSpinw RNA II Kit (Macherey-Nagel GmbH & Company
KG). RNA quality and quantity were determined on an Agilent
2100 Bioanalyzer (Agilent). Subsequently, 100 ng of total RNA
were reverse-transcribed into complementary DNA in a final
volume of 20ml using the SuperScriptw III Reverse Trans-
criptase First-Strand complementary DNA Synthesis System
(Invitrogen). The complete reaction mix was incubated for
5 min at 258C, 60 min at 508C, and 15 min at 708C in a Sure
Cycler 8800 (Agilent Technologies). Primers for MCT1, TNF-a,
IFN-g, IL-8, 60S ribosomal protein L19 (RPL19), b2-microglobu-
lin, succinate dehydrogenase subunit A (SDHA), b-actin and
TATA box-binding protein (TBP) were designed based on
published sequences. Porcine (RPL19 and SDHA) and human
(b-actin and TBP) housekeeping genes were selected for data
normalisation. Primer information and annealing temperatures
are summarised in Table 2. Quantitative real-time PCR was
performed in a total volume of 25ml, which contained 12·5ml
Brilliant II SYBR Green QPCR Master Mix with Low ROX
(Agilent Technologies), 0·5ml of each primer (10mM), 10·5ml
of water and 1ml complementary DNA. The real-time quantitat-
ive PCR was performed on a Stratagene MX3000p (Stratagene)
with general cycling conditions as follows: one cycle of dena-
turation at 958C for 15 min, followed by forty cycles with 30 s
denaturation at 958C, 30 s annealing and 30 s extension at
728C. Gene expression data were normalised, and times-fold
expression was calculated based on mean Ct values of the
housekeeping genes using real-time PCR efficiency according
to the method proposed by Pfaffl(25).
Statistical analysis
Data from the in vivo study were analysed using general linear
model procedures in SPSS (version 21.0; SPSS, Inc.) with SBP
and CP and their interaction as sources of variation. Pearson’s
correlation analysis was performed to determine the corre-
lation between colonic metabolite concentrations and relative
gene expression data in pigs. The effects of increasing concen-
trations of selected metabolites on gene expression in Caco-2
cells were analysed by ANOVA and polynomial (linear, quad-
ratic and cubic) contrasts, corrected for unequal spacing of
treatment concentrations. Electrophysiological data from
Ussing chambers and gene expression data from the ex vivo
and in vitro experiments were analysed by one-way ANOVA
followed by Tukey’s honestly significant difference test. For
non-normally distributed data, the Kruskal–Wallis test was
applied to determine group differences, and groups were
separated using the Mann–Whitney test. Differences at
P,0·05 were considered significant. Data are presented as
means with their standard errors, unless otherwise stated.
Results
During the in vivo study, all pigs remained in good health con-
dition, and no clinical signs of diarrhoea or health impairment
were observed. BW gain, feed intake and final BW did not
differ significantly between the treatments, although pigs fed
SBP diets had numerically lower BW gain and final BW
(data not shown).

















Metabolite concentrations in the colonic digesta have been
described previously(22). Briefly, pigs fed dietary SBP had
higher concentrations of lactate and acetate and lower propio-
nate concentration in the colonic digesta (P,0·05), whereas
pigs fed diets high in CP exhibited higher concentrations of
butyrate, NH3 and biogenic amines (P,0·05). Inclusion
of SBP in high-CP diets led to lower concentrations of some
protein-derived metabolites, such as NH3, cadaverine, p-cresol
and indole (P,0·05), but the values were still higher as with
low-CP diets. Other metabolites such as putrescine, histamine,
phenol, 4-ethylphenol or 3-methylindol were unaffected.
Lactate concentration was slightly lower (P,0·10) in high-CP
diet-fed pigs, whereas inclusion of both CP and SBP led to
slightly higher (P,0·10) levels of SCFA.
The relative gene expression of MCT1, IL-8, TNF-a and
IFN-g in the colon of pigs fed the different diets is given in
Table 3. The expression of MCT1 was lower (P,0·05) in
pigs fed high-CP diets, irrespective of SBP. In contrast, the
expression of IL-8, TNF-a and IFN-g was higher (P,0·05) in
pigs fed high-CP diets. The inclusion of dietary SBP had no
effect on these gene expression patterns. In addition, no inter-
action was observed, indicating that dietary CP level was the
main factor that influenced the expression of MCT1, IL-8,
TNF-a and IFN-g, irrespective of dietary SBP inclusion.
Pearson’s correlation analysis was performed to determine
the correlation between the metabolite concentrations in the
colonic digesta and the relative gene expression of MCT1,
IL-8, TNF-a and IFN-g in colonic tissue (Table 4). A positive
correlation (P,0·05) occurred between MCT1 expression and
L-lactate concentration, whereas NH3 and putrescine concen-
trations were negatively correlated with MCT1 expression
(P,0·05). IL-8 gene expression was negatively correlated with
L-lactate (P,0·05) and positively linked with NH3, putrescine,
phenol and 4-ethylphenol (P,0·05). TNF-a expression also
negatively correlated with L-lactate and positively correlated
with acetate, NH3, putrescine and histamine (P,0·05). Finally,
IFN-g expression was only positively correlated with histamine
and 4-ethylphenol concentrations (P,0·05).
Table 2. List of the primers used in the present study
Targets Species Sequences of primers (50 to 30) AT (8C) References
b2-Microglobulin Porcine F: CCCCGAAGGTTCAGGTTTAC 60 Martin et al.
(24)
R: CGGCAGCTATACTGATCCAC
SDHA Porcine F: CAAACTCGCTCCTGGACCTC 60 Martin et al.(24)
R: CCGGAGGATCTTCTCACAGC
RPL19 Porcine F: GCTTGCCTCCAGTGTCCTC 60 Pieper et al.(17)
R: GCGTTGGCGATTTCATTAG
MCT1 Porcine F: GGAGACCAGTATAGACGCTGC 60 Present study
R: CTCCTCCTCTTTGGGGCTTC
IL-8 Porcine F: GGTCTGCCTGGACCCCAAGGAA 60 Present study
R: TGGGAGCCACGGAGAATGGGTT
TNF-a Porcine F: CAAGCCACTCCAGGACCCCCT 60 Present study
R: AGAGTCGTCCGGCTGCCTGT
IFN-g Porcine F: TCCAGCGCAAAGCCATCAGTG 58 Present study
R: ATGCTCTCTGGCCTTGGAACATAGT
b-Actin Human F: TTGCCGACAGGATGCAGAAGGA 60 Present study
R: AGGTGGACAGCGAGGCCAGGAT
TBP Human F: TGCACAGGAGCCAAGAGTGAA 60 Present study
R: CACATCACAGCTCCCCACCA
TNF-a Human F: GGCCTCTGTGCCTTCTTTTG 60 Present study
R: CCTCAGCAATGAGTGACAGT
IL-8 Human F: GGTGCAGTTTTGCCAAGGAG 60 Present study
R: TGGGGTGGAAAGGTTTGGAG
MCT1 Human F: CAGCAGAATCTCCGGACCAG 60 Present study
R: TACCCTTCAGCCCCATGGAT
AT, annealing temperature; F, forward; R, reverse; SDHA, succinate dehydrogenase subunit A; RPL19, 60S ribosomal protein
L19; MCT1, monocarboxylate transporter 1; IFN-g, interferon g; TBP, TATA box-binding protein.
Table 3. Relative gene expression (fold change) of monocarboxylate transporter 1 (MCT1), IL-8, TNF-a and
interferon g (IFN-g) in the colon of pigs fed diets high or low in dietary crude protein (CP) with or without the
addition of sugarbeet pulp (SBP)
(Mean values with their standard errors; n 6)
Low CP High CP P*
Genes Low SBP High SBP Low SBP High SBP SEM CP SBP CP£SBP
MCT1 1·00 1·15 0·57 0·56 0·13 ,0·05 NS NS
IL-8 1·34 1·14 3·36 3·65 1·69 ,0·05 NS NS
TNF-a 1·09 0·90 1·57 1·74 0·13 ,0·05 NS NS
IFN-g 1·08 1·01 1·62 1·96 0·32 ,0·05 NS NS
*P values indicate the main effects for CP and SBP, respectively.

















Colonic tissue from pigs fed commercial standard diets was
mounted on Ussing chambers and mucosally exposed to
different metabolites. Changes in short-circuit current were
found to be higher (P,0·05) after the mucosal addition
of NH4Cl compared with control chambers and chambers
treated with Na-butyrate and TNF-a, where practically no
biologically relevant change occurred (data not shown). The
expression of MCT1, IL-8, TNF-a and IFN-g was subsequently
analysed. MCT1 gene expression was higher (P,0·05) after
Na-butyrate treatment and lower (P,0·05) after exposure to
NH4Cl and TNF-a compared with the untreated controls
(Fig. 1(A)). The expression of IL-8 was only increased
(P,0·05) after exposure to TNF-a, whereas all the other treat-
ments had no effect (Fig. 1(B)). The expression of TNF-a was
only increased (P,0·05) after tissue exposure to NH4Cl,
whereas Na-butyrate or TNF-a had no effect (Fig. 1(C)). Finally,
Na-butyrate decreased (P,0·05) IFN-g gene expression,
whereas all the other treatments did not (Fig. 1(D)).
Increasing concentrations of Na-butyrate, NH4Cl and TNF-a
were used to study the possible dose-dependent effects in
Caco-2 cells (Table 5). The expression of MCT1 was increased
with Na-butyrate treatment and decreased with NH4Cl and
TNF-a treatments (linear, P,0·05), respectively. Linear and
quadratic effects (P,0·05) were also observed for IL-8 gene
expression after Na-butyrate and TNF-a treatments, respect-
ively. Similarly, TNF-a gene expression showed a quadratic
response (P,0·05) towards increasing concentrations of
NH4Cl, and a linear and quadratic response (P,0·05) after
exposure to TNF-a.
Discussion
Previous studies(10,11,26) have shown that diets high in resistant
starch or soluble fibres up-regulate MCT1 expression in the
large intestine of pigs. However, to date, the influence of diet-
ary protein and protein-derived bacterial metabolites on MCT1
expression is largely unknown. In the present study, high CP
Table 4. Pearson’s correlation of the microbial metabolite concen-
trations in the colonic digesta with the relative gene expression of
monocarboxylate transporter 1 (MCT1), IL-8, TNF-a and interferon g
(IFN-g) in the colonic tissue of pigs fed diets high or low in dietary crude
protein with or without the addition of sugarbeet pulp*
MCT1 IL-8 TNF-a IFN-g
L-Lactate 0·53 20·50 20·62 –
Acetate – – 0·49 –
NH3 20·54 0·46 0·43 –
Putrescine 20·42 0·45 0·53 –
Histamine – – 0·49 0·55
Phenol – 0·49 – –
4-Ethylphenol – 0·52 – 0·76



















































































































Control Na-butyrate NH4CI TNF-α Control Na-butyrate NH4CI TNF-α
Control Na-butyrate NH4CI TNF-αControl Na-butyrate NH4CI TNF-α
Fig. 1. Relative gene expression (fold change) of (A) monocarboxylate transporter 1 (MCT1), (B) IL-8, (C) TNF-a and (D) IFN-g in colonic tissue after the mucosal
addition of Na-butyrate, NH4Cl or TNF-a, respectively. Values are means, with their standard errors represented by vertical bars.
a,b Mean values with unlike
letters were significantly different (P,0·05).

















dietary level led to the down-regulation of MCT1 expression
in the colon of pigs, irrespective of dietary SBP inclusion.
The fact that no interaction between CP and SBP was
observed could be either due to data variability or the number
of animals per treatment group (n 6). In contrast, inclusion of
SBP into high-CP diets did not reduce the levels of protein-
derived metabolites to similar levels as with low-CP diets(22).
Previous findings have also shown that gene expression of
cytokines in the colon increased with high-CP diets, irres-
pective of dietary fermentable carbohydrate inclusion(17). This
is, to a certain extent, in contrast to our initial hypothesis;
however, it can be concluded that in the present study, the
decreased expression of MCT1 coincided with increased
luminal availability of protein fermentation products such
as NH3, and the concomitantly increased pro-inflammatory
cytokine expression in the colonic mucosa.
The role of MCT1 in the transport of butyrate into colono-
cytes has been well studied. MCT1 is present on the luminal
membrane of the human and pig colon, and is involved in
the uptake of butyrate by both proton co-transport and
anion-exchange mechanisms, as has been discussed in the
literature(4,27,28). It has been demonstrated that butyrate
uptake is enhanced at acidic pH and inhibited or reduced
by structural analogues such as acetate, propionate, L-lactate
or pyruvate(4,27). In addition to its role as a colonic fuel, buty-
rate is involved in the maintenance of colonic homeostasis by
regulating the expression of genes linked to cellular processes,
including proliferation, differentiation or apoptosis(29).
Previous studies on human colonic AA/C1 cells have
revealed that butyrate increases MCT1 mRNA and protein
expression(13). Other studies have shown that MCT1 promoter
activity is stimulated by Na-butyrate in a dose-dependent way,
and that this is related to the NF-kB signalling pathway(14).
Coherent with these results, earlier studies have found
higher MCT1 expression in pigs fed high levels of fermentable
carbohydrates that promoted higher levels of colonic
butyrate(10,26). However, the sole inclusion of SBP to a diet
without an increase in colonic butyrate concentration was
not able to increase MCT1 expression in the present study.
In contrast to previous studies where SBP inclusion stimulated
butyrate formation in the colon(30,31), such an increase was not
observed in the present study where only lactate and acetate
concentrations were affected by the inclusion of dietary SBP.
If butyrate specifically promotes MCT1 expression in the
colon, the question arises why higher butyrate absorption
was not accompanied by an increment in MCT1 expression
when induced by a diet high in CP. Although SCFA are
mainly derived from saccharolytic fermentation, they can
also be derived from amino acids, such as lysine or histidine,
through reductive deamination(32). However, apart from
butyrate, our diets high in CP also increased the luminal
concentrations of NH3 and biogenic amines. The latter were
inversely associated with the expression of MCT1, and
positively correlated with pro-inflammatory cytokines. An
up-regulation of pro- and anti-inflammatory cytokines in the
colon of pigs has also been observed in a previous study
when high-protein diets were fed(17). Interestingly, chronic
intestinal inflammation (inflammatory bowel disease) is well
known to coincide with reduced MCT1 expression in the
intestinal mucosa(16). Furthermore, treatment with the pro-
inflammatory cytokines TNF-a and IFN-g in colonic HT29
cells down-regulated MCT1 mRNA and protein expression(16).
The present results suggest that NH3 and other protein-derived
metabolites present in the lumen may entail inflammatory
responses in the colonic mucosa, which negatively influence
the expression of MCT1. This may provide an interesting
link between impaired protective effects of butyrate on the
colonic epithelium and pro-inflammatory conditions in the
colon of pigs fed high-protein diets. In fact, the higher buty-
rate concentration in the colonic lumen of piglets fed a
Table 5. Relative gene expression (fold change) of monocarboxylate transporter 1 (MCT1), IL-8 and TNF-a in Caco-2 cells after
the addition of different concentrations of Na-butyrate, NH4Cl or TNF-a, respectively
(Mean values with their standard errors; n 6).
Substance (concentration in incubation medium)
Na-butyrate (mmol/l)
Genes 0 10 20 50 SEM Linear Quadratic Cubic
MCT1 1·05 1·33 1·44 1·62 0·05 ,0·05 NS NS
IL-8 0·95 0·51 0·50 0·64 0·04 ,0·05 ,0·05 NS
TNF-a 1·02 0·82 0·82 1·20 0·14 NS NS NS
NH4Cl (mmol/l)
0 5 10 20
MCT1 0·95 0·93 0·91 0·72 0·09 ,0·05 NS NS
IL-8 0·95 0·95 0·99 1·06 0·27 NS NS NS
TNF-a 1·20 0·57 0·59 0·87 0·26 NS ,0·05 NS
TNF-a (ng/ml)
0 25 50 100
MCT1 1·04 1·09 0·65 0·73 0·09 ,0·05 NS NS
IL-8 1·19 48·75 44·34 49·36 7·46 ,0·05 ,0·05 NS
TNF-a 0·91 6·87 6·52 4·89 2·73 ,0·05 ,0·05 NS

















high-protein diet might, in part, even be a consequence of
decreased butyrate absorption due to decreased MCT1
expression. When assuming that butyrate is accumulated in
the lumen because of decreased uptake by colonocytes, it
follows that the intracellular concentration of butyrate in colo-
nocytes might have been unchanged or even lower on a
high-protein diet despite higher luminal concentrations. Such
concept of ‘cellular butyrate starvation’ upon inflammatory
down-regulation of MCT1 expression is well established as a
mechanism contributing to the progression of inflammatory
bowel disease(16).
To further assess the individual effects of NH3, Na-butyrate
and TNF-a on the expression of MCT1 and cytokines in
the target tissue, the pig colonic mucosa was mounted on
Ussing chambers. In agreement with previous reports, Na-
butyrate resulted in a higher expression of MCT1, whereas
TNF-a had an inhibitory effect(13,16). Butyrate has anti-
inflammatory properties in human intestinal epithelial cells,
which is probably mediated by the inhibition of the NF-kB
pathway(33,34). Furthermore, colonic and systemic immuno-
reactivity was reduced after a long-term feeding experiment
with resistant starch in pigs, possibly due to an increased
luminal concentration of butyrate(35). In contrast, NH3 is a
putatively toxic metabolite derived from amino acid fermenta-
tion in the large intestine. Some studies have confirmed the
potential toxicity on the gut epithelium with adverse effects
on both colonocyte metabolism and barrier function(1,3,19).
There is also evidence for NH3 as a precursor of cancer and
inflammatory bowel diseases in humans(36–38). NH3 has
been shown to interfere with oxidative metabolism in colono-
cytes(39). Moreover, it has been associated with a mucosal
inflammatory response, which, in turn, can also reduce buty-
rate oxidation(40). Therefore, a reduced expression of MCT1
under inflammatory conditions may result in reduced uptake
and oxidation of butyrate. In support of the in vivo findings,
colonic tissue treated with NH4Cl exhibited lower MCT1
and up-regulated TNF-a gene expression. Similarly, colonic
tissue had also reduced MCT1 expression after treatment
with TNF-a, while IL-8 was markedly increased in parallel.
Although no direct effect of TNF-a on MCT1 promoter activity
or butyrate uptake has been reported previously in Caco-2
cells(14), the present results reinforce the notion that MCT1 is
down-regulated by pro-inflammatory cytokines.
Finally, increasing concentrations of the same substrates
were used to study dose-dependent effects in Caco-2 cells.
The regulation of MCT1 by Na-butyrate and TNF-a is in agree-
ment with the results obtained from the ex vivo experiments
and previous studies(13,14,16). The stimulation of Caco-2 cells
with increasing concentrations of Na-butyrate increased
MCT1 expression, whereas treatment with NH4Cl and TNF-a
had opposite effects, supporting the idea of the regulation
of MCT1 gene expression by protein-derived metabolites
such as NH3 and pro-inflammatory signalling. However, the
underlying mechanisms need further elucidation.
In conclusion, the present study shows that diets high in CP
reduce the expression of MCT1 in the colon of pigs, even
when higher concentrations of butyrate are present in the
gut lumen. This effect seems to be related to an inflammatory
response of the colonic mucosa triggered by metabolites
derived from the bacterial fermentation of protein. While we
provide data that NH3 is one important fermentation product
involved in the down-regulation of MCT1 gene expression,
the present correlation analyses from the in vivo study suggest
that other metabolites (e.g. putrescine) could have also been
involved. Further studies are required to investigate the
complete portfolio of luminal protein-derived fermentation
products that affect MCT1 gene expression and their precise
mechanism of action.
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